01.07.2024 08:11:48 - dpa-AFX: *AZN : LYNPARZA AND IMFINZI COMBINATION RECOMMENDED FOR APPROVAL IN EU BY CHMP FOR RECURRENT ENDOMETRIAL CANCER

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
ASTRAZENECA PLC DL-,25 886455 Xetra 146,500 18.07.24 11:12:11 +0,900 +0,62% 146,550 146,700 146,950 145,600

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH